23andMe: Transitioning to a Healthcare Company

By Staff Reporters

***

***

23andMe is rolling out a $1,188-per-year tool to identify users’ genetic vulnerabilities as part of its broader transition from a DNA-testing service into a healthcare company.

READ MORE HERE: HACKED: 23andMe

COMMENTS APPRECIATED

Thank You

***

***

Leave a comment